UPDATE: Bioclinica, Inc. (BIOC) Reports Inline Q1 EPS of 8c; Guides to High End for FY12
Tweet Send to a Friend
(Updated - May 9, 2012 3:03 PM EDT)
Bioclinica, Inc. (NASDAQ: BIOC) reported Q1 EPS of $0.08, inline with the analyst estimate of $0.08. Revenue for the quarter came in at $22.69 million versus the consensus estimate of $18.4 million.
Bioclinica, Inc. sees FY2012 EPS of $0.36-$0.42 vs. consensus of $0.36. Reiterating expectations for full-year 2012 service revenue to be in the range of $73 to $77 million.
For earnings history and earnings-related data on Bioclinica, Inc. (BIOC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Bioclinica, Inc. (NASDAQ: BIOC) reported Q1 EPS of $0.08, inline with the analyst estimate of $0.08. Revenue for the quarter came in at $22.69 million versus the consensus estimate of $18.4 million.
Bioclinica, Inc. sees FY2012 EPS of $0.36-$0.42 vs. consensus of $0.36. Reiterating expectations for full-year 2012 service revenue to be in the range of $73 to $77 million.
For earnings history and earnings-related data on Bioclinica, Inc. (BIOC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Ross Stores, Inc. (ROST) Reports In-Line Q1 EPS, Raises Guidance
- UPDATE: Sears Holding Corp. (SHLD) Reports Q1 Loss of $1.29
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
